L&C Bio Co., Ltd (290650.KQ)
KRW 21400.0
(0.23%)
KRW 21400.0
(0.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.13 Billion | -6.07 Billion | 10.9 Billion | 7.41 Billion | 6.43 Billion | 3.84 Billion |
| Net Income | 48.36 Billion | 5.69 Billion | 15.58 Billion | 12.14 Billion | 8.45 Billion | 5.09 Billion |
| Depreciation & Amortization | 7.39 Billion | 4.5 Billion | 2.9 Billion | 1.58 Billion | 1.08 Billion | 481.82 Million |
| Deferred income taxes | - | 1.47 Billion | -1.03 Billion | -4.37 Billion | - | 872.77 Million |
| Stock-based compensation | 138.87 Million | 375.83 Million | 727.41 Million | 290.47 Million | - | 2.09 Million |
| Change in working capital | -26.46 Billion | -21.4 Billion | -7.18 Billion | -2.36 Billion | -4 Billion | -2.4 Billion |
| Other non-cash items | -7.78 Billion | 3.27 Billion | -81.22 Million | 133.5 Million | 893.78 Million | -204.36 Million |
| Investing Cash Flow | 25.44 Billion | -83.63 Billion | -20.48 Billion | 823.5 Million | -15.81 Billion | -16.76 Billion |
| Investments in PPE | -24.98 Billion | -37.7 Billion | -11.42 Billion | -3.05 Billion | -2 Billion | -4.76 Billion |
| Acquisitions | 1.06 Billion | -42.41 Billion | 2.62 Billion | -3.5 Billion | -1 Billion | 1.5 Billion |
| Investment purchases | -136.63 Billion | -11.3 Billion | -18.65 Billion | -15.83 Billion | -40.92 Billion | -34.85 Billion |
| Sales/Maturities of investments | 186.49 Billion | 7.94 Billion | 12.41 Billion | 22.9 Billion | 29.39 Billion | 22.92 Billion |
| Other Investing Activities | -494.45 Million | -150.74 Million | -5.44 Billion | 305.2 Million | -1.27 Billion | -1.57 Billion |
| Financing Cash Flow | -4.96 Billion | 78.92 Billion | 4.69 Billion | 1.26 Billion | 526.86 Million | 31.42 Billion |
| Debt repayment | -1.42 Billion | -8.4 Billion | -6 Billion | -10 Billion | - | -462.5 Million |
| Dividends payments | -1.11 Billion | -1.11 Billion | -1.07 Billion | -729.32 Million | - | - |
| Common Stock Repurchased | -840 Million | - | -2.04 Billion | -12.68 Billion | - | - |
| Common Stock Issuance | - | - | -663 Million | 75 Million | 374.56 Million | 30.43 Billion |
| Other Financing Activities | -1.49 Billion | 88.45 Billion | 14.48 Billion | 24.59 Billion | 152.29 Million | 1.44 Billion |
| Accounts receivables | -5.54 Billion | -68.34 Million | -3.28 Billion | -664.3 Million | -2.44 Billion | -2.1 Billion |
| Accounts payables | -1.15 Billion | 1.7 Billion | 754.1 Million | 75.95 Million | -44.02 Million | -43.18 Million |
| Inventory | -12.15 Billion | -23.26 Billion | -4.55 Billion | -2.15 Billion | -912.35 Million | -595.58 Million |
| Other working capital | -7.61 Billion | 227.86 Million | -107.93 Million | 378.3 Million | -604.33 Million | 342.51 Million |
| Cash at beginning of period | 6.59 Billion | 17.38 Billion | 22.26 Billion | 12.76 Billion | 21.62 Billion | 3.11 Billion |
| Cash at end of period | 14.94 Billion | 6.59 Billion | 17.38 Billion | 22.26 Billion | 12.76 Billion | 21.62 Billion |
| Capital Expenditure | -24.98 Billion | -37.7 Billion | -11.42 Billion | -3.05 Billion | -2 Billion | -4.76 Billion |
| Effect of forex changes on cash | 11.31 Million | -9.18 Million | 20.00 | -3.47 Million | 20.00 | -869.59 Thousand |
| Net cash flow / Change in cash | 8.35 Billion | -10.78 Billion | -4.88 Billion | 9.5 Billion | -8.85 Billion | 18.5 Billion |
| Free Cash Flow | -37.11 Billion | -43.77 Billion | -521.14 Million | 4.36 Billion | 4.42 Billion | -922.12 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.06 Billion | 1.55 Billion | 48.36 Billion | -3.4 Billion | 49.36 Billion | 1.49 Billion |
| Depreciation & Amortization | 1.58 Billion | 1.46 Billion | 7.39 Billion | 3.15 Billion | -1.46 Billion | -1.43 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 29.02 Million | 138.87 Million | 27.97 Million | - | - |
| Change in working capital | -908.36 Million | -2.11 Billion | -26.46 Billion | -8.23 Billion | -8.23 Billion | -4.15 Billion |
| Other non-cash items | -9.71 Billion | 3.32 Billion | -7.78 Billion | 8.5 Billion | -41.23 Billion | 2.63 Billion |
| Investing Cash Flow | 8.84 Billion | -5.73 Billion | 25.44 Billion | 7.77 Billion | 16.37 Billion | -1.34 Billion |
| Investments in PPE | -2.09 Billion | -523.76 Million | -24.98 Billion | -21.17 Billion | -745.64 Million | -2.05 Billion |
| Acquisitions | 893 Million | 1.13 Billion | 1.06 Billion | 427 Million | 7 Million | 628.7 Million |
| Investment purchases | -12.78 Billion | -22.96 Billion | -136.63 Billion | -27.77 Billion | -105.69 Billion | -78 Million |
| Sales/Maturities of investments | 23.2 Billion | 16.75 Billion | 186.49 Billion | 56.44 Billion | 22.39 Billion | 1.07 Billion |
| Other Investing Activities | 10.94 Billion | -129.15 Million | -494.45 Million | -143.08 Million | 100.42 Billion | -923.28 Million |
| Financing Cash Flow | -2.43 Billion | -407.12 Million | -4.96 Billion | -80.31 Million | -6.49 Billion | 1.18 Billion |
| Debt repayment | -2.06 Billion | -41.64 Million | -1.42 Billion | -1.79 Billion | -6.06 Billion | -3.24 Billion |
| Dividends payments | -2.26 Billion | - | -1.11 Billion | - | - | -1.11 Billion |
| Common Stock Repurchased | - | - | -840 Million | - | - | -840 Million |
| Common Stock Issuance | - | - | - | - | - | 6.39 Billion |
| Other Financing Activities | 1.9 Billion | 1 Billion | -1.49 Billion | -1.42 Billion | -431.86 Million | -10 Million |
| Accounts receivables | -1.31 Billion | 888.03 Million | -5.54 Billion | 778.94 Million | -4.44 Billion | -1.62 Billion |
| Accounts payables | 3.03 Billion | -498.36 Million | -1.15 Billion | -505 Million | -1.05 Billion | -2.15 Billion |
| Inventory | -1.78 Billion | -348.6 Million | -12.15 Billion | -769.91 Million | -3.12 Billion | -3.89 Billion |
| Other working capital | 2.18 Billion | -2.15 Billion | -7.61 Billion | -7.73 Billion | 397.22 Million | 3.52 Billion |
| Cash at beginning of period | 10.14 Billion | 14.94 Billion | 6.59 Billion | 14.04 Billion | 5.74 Billion | 8.34 Billion |
| Cash at end of period | 8.64 Billion | 10.14 Billion | 14.94 Billion | 14.94 Billion | 14.04 Billion | 5.74 Billion |
| Capital Expenditure | -2.09 Billion | -523.76 Million | -24.98 Billion | -21.17 Billion | -745.64 Million | -2.05 Billion |
| Effect of forex changes on cash | 55.9 Million | 7.01 Million | 11.31 Million | -10.58 Million | -1.84 Million | 14.53 Million |
| Net cash flow / Change in cash | -1.5 Billion | -4.8 Billion | 8.35 Billion | 899.65 Million | 8.3 Billion | -2.59 Billion |
| Free Cash Flow | -10.06 Billion | 805.84 Million | -37.11 Billion | -27.96 Billion | -2.31 Billion | -3.5 Billion |
OCAX
FNRC
002976
CLN
ENTRINT
JETAIRWAYS